Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to divest its international enterprises in the months to come. The investment ...
I am downgrading Stryker Corporation to a Hold rating with a fair value of $380 per share, despite strong performance and growth prospects. Stryker's Mako spine and shoulder applications are set to ...
Virtua Health has introduced a new robotic-assisted spine surgery method. This GPS-like navigation system is the first of its kind in the Philadelphia and South Jersey area. The navigation system — ...
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of ...
On Jan. 28, major orthopedic and spine device manufacturer Stryker announced plans to sell off its U.S. spinal implants business. 1. Stryker’s U.S. spine segment will be sold to investment firm ...
PORTAGE, Michigan - Medical (TASE:PMCN) technology company Stryker (NYSE:SYK), a prominent player in the Healthcare Equipment ...
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to ...
Wall Street analysts rerated Stryker Corp (NYSE:SYK) Wednesday after the company’s fourth-quarter print. Stryker reported quarterly earnings of $4.01 per share, which beat the analyst consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results